Inactive Instrument

Philab Holdings Corp.

DNA

PHY6900R1015

Advanced Medical Equipment & Technology

Philab Holdings Corp. Announces Resignation of Edgardo Faylona as Independent Director

August 29, 2019 at 05:12 am IST

Philab Holdings Corp. announced Dr. Edgardo Faylona resigned as Independent Director of DNA effective 19 August 2019.

Latest news about Philab Holdings Corp.

Philab Holdings Corp. Announces Board Changes	13/20/13	CI
Philab Holdings Corp. Announces Resignation of Robert W. van Zwieten, President and CEO	13/20/13	CI
Philab Holdings Corporation and Prenetics Limited Sign Memorandum of Agreement	16/19/16	CI
Philab Holdings Corporation has Changed its Name to DNA Holdings Corporation	16/19/16	CI
Philab Holdings Corp. Elects Jose Miguel Vergara as Acting Chairman	09/19/09	CI
Philab Holdings Corp. Announces Resignation of Thomas Hector Navasero as Chairman of the Board	06/19/06	CI
Philab Holdings Corp. Announces Labor Case Regarding Illegal Dismissal	05/19/05	CI
Philab Holdings Corp. Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended Sep. 30, 2019	20/19/20	CI
Philab Holdings Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2019	12/19/12	CI
Philab Holdings Corp. Announces Unaudited Consolidated Earnings Results for the Year Ended December 31, 2018	12/19/12	CI
Philab Holdings Corp. Reports Earnings Results for the First Quarter Ended March 31, 2018	06/19/06	CI
Philab Holdings Corp. Appoints Atty Jason C. Esperante as Corporate Secretary of the Company	31/19/31	CI
Philab Holdings Corp. Announces Resignation of Hector Thomas Navasero as Chairman	09/19/09	CI
Philab Holdings Corp. Announces Executive Appointments	01/19/01	CI
Philab Holdings Corp. Announces Management Appointments	20/19/20	CI
Philab Holdings Corp. Announces Retirement of Executives	06/19/06	CI
Philab Holdings Corp. Announces Resignation of Edgardo Faylona as Independent Director	29/19/29	CI
Philab Holdings Corp. Announces Management Changes	26/19/26	CI
Hector Thomas A. Navasero acquired 24.24% stake in Philab Holdings Corp. from Rewa Romina Cristina L. Santos for approximately PHP 130 million.	24/19/24	CI
Philab Holdings Corp. Announces the Resignation of Arlene R Castillo as Corporate Information Officer and Chief of Staff	26/19/26	CI
Philab Holdings Corp. Announces Change in Corporate Business Address	24/19/24	CI
Philab Holdings Corp. Appoints Atty. Geraldine Elaine D. Laqui as Assistant Corporate Secretary	14/19/14	CI
Philab Holdings Corp. Reports Earnings Results for the First Nine Months of 2018; Provides Profitability Guidance for the Year 2019	17/18/17	CI
Philab Holdings Corp. cancelled the acquisition of 66.66% stake in Sydenham Laboratories Inc.	11/18/11	CI
Philab Holdings Corp. Announces Resignation of Sylvia A. Navasero as Director and Treasurer	04/18/04	CI

Philab Holdings Corp., formerly Alterra Capital Partners, Inc., is a holding company. The Company conducts its business through its subsidiary, Philab Industries, Inc. (Philab). Philab is engaged in the healthcare sector, particularly the life sciences tools and services industry, by supplying laboratory equipment, furniture, and supplies for medical and scientific research to both private and public institutions. Its life sciences tools include laboratory equipment and supplies, such as autoclaves, microscopes, fume hoods, reagents, and learning materials. Its life sciences services include delivery, installation, maintenance, repair and upgrade of life sciences tools. Its In Vitro Diagnostic are medical devices and accessories used for the diagnosis of communicable and non-communicable diseases. It has its own brand of self-test kits, LabIt, designed to be used in one's own home. It is also focused on providing Whole Genome Sequencing and healthcare management-related services.

Sector

Advanced Medical Equipment & Technology

More about the company